NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  Ortho Clinical Diagnostics Holdings plc

Ortho Clinical Diagnostics Holdings plc

orthoclinicaldiagnostics.com ↗
—
Latest disclosed NPS
no score published
1
NPS entries
0 with a number
98%
NRR
19 Mar 2021
99%
GRR
4 Jan 2021

In their words

“Our superior service and customer performance contribute to our revenue retention rate of approximately 98% in 2021”
— Ortho Clinical Diagnostics Holdings plc · SEC 10-K annual report · filed 8 Mar 2022
“High revenue retention rate of approximately 98% in 2020”
— Ortho Clinical Diagnostics Holdings plc · SEC 10-K annual report · filed 19 Mar 2021
“High revenue retention rate of approximately 99% in 2019”
— Ortho Clinical Diagnostics Holdings plc · SEC S-1 IPO prospectus · filed 4 Jan 2021

NPS disclosures (1)

Search the database →

11 Jan 2022
NPSProgram

…Decrease in service interventions* 100% Ortho teams trained in Customer Excellence Closed Loop Process Improvement 82% Improvement in Global NPS Score (2015 – 2020) 89% Same Day Fix Speed of Response People Reliability ORTHO CARE™ Key Drivers…

— Ortho Clinical Diagnostics Holdings plc · SEC 8-K filing · filed 11 Jan 2022
SEC 8-K filing ↗

Retention disclosures (3)

Open in the retention database →

8 Mar 2022
Retention98%

Retention rate: 98% (FY2021) — “Our superior service and customer performance contribute to our revenue retention rate of approximately 98% in 2021”

— Ortho Clinical Diagnostics Holdings plc · SEC 10-K annual report · filed 8 Mar 2022
SEC 10-K annual report ↗
19 Mar 2021
NRR98%

Net revenue retention: 98% (2020) — “high revenue retention rate of approximately 98% in 2020”

— Ortho Clinical Diagnostics Holdings plc · SEC 10-K annual report · filed 19 Mar 2021
SEC 10-K annual report ↗
4 Jan 2021
GRR99%

Gross revenue retention: 99% (FY2019) — “high revenue retention rate of approximately 99% in 2019”

— Ortho Clinical Diagnostics Holdings plc · SEC S-1 IPO prospectus · filed 4 Jan 2021
SEC S-1 IPO prospectus ↗

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.